| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $130K | +132.1% |
| R&D Expense | $13.2M | +75.9% |
| SG&A Expense | $11.0M | +14.3% |
| Operating Income | -$24.0M | -40.9% |
| Pre-tax Income | -$19.2M | -72.3% |
| Income Tax | $18K | — |
| Net Income | -$19.2M | -72.2% |
| EPS (Basic) | -$1.91 | -26.5% |
| EPS (Diluted) | -$1.91 | -26.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.1M | -16.8% |
| Current Assets | $6.1M | +7.1% |
| Total Assets | $7.0M | +3.4% |
| Current Liabilities | $3.6M | +50.6% |
| Total Liabilities | $7.0M | +12.4% |
| Stockholders' Equity | -$37K | -105.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.0M | -4.8% |
| Capital Expenditures | $59K | +168.2% |
| Investing Cash Flow | -$59K | -168.2% |
| Financing Cash Flow | $17.4M | +31.8% |
| Free Cash Flow | -$18.0M | -5.0% |